CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)

被引：0
|
作者：
Teng, Chia-Chen [1 ]
Singh, Rakesh [2 ]
Kong, Sheldon [2 ]
Djaraher, Rachel [1 ]
Williamson, Todd [2 ]
Farej, Ryan [2 ]
Willey, Vincent [1 ]
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Bayer US LLC, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
254
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [2] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [3] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [4] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    [J]. DIABETES, 2021, 70
  • [5] Impact of Finerenone on Cardiac Biomarkers in Patients With T2D and Chronic Kidney Disease
    Berger, Mario
    Scalise, Andrea
    Kramer, Frank M.
    Paraschin, Karen
    Goea, Laura
    Kolkhof, Peter
    Rohwedder, Katja
    Skubala, Adam
    Voss, Sebastian
    Zannad, Faiez
    Rossing, Peter
    [J]. CIRCULATION, 2023, 148
  • [6] Physicians' Chronic Kidney Disease (CKD) Awareness over Time in Type 2 Diabetes (T2D)
    Schempf, John
    Freese, Rebecca L.
    Caramori, Luiza
    Harindhanavudhi, Tasma
    [J]. DIABETES, 2020, 69
  • [7] Finerenone and Kidney Outcomes in Patients with CKD and T2D: Results from FIDELITY
    Bakris, George L.
    Ruilope, Luis M.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Fried, Linda F.
    Roy-Chaudhury, Prabir
    Sarafidis, Pantelis
    Ahlers, Christiane
    Joseph, Amer
    Brinker, Meike D.
    Lawatscheck, Robert
    Agarwal, Rajiv
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B6 - B6
  • [8] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [9] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [10] A Prediction Model on Incident End-Stage Kidney Disease (ESKD) among Individuals with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    [J]. DIABETES, 2022, 71
12345